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A b s tra c t .  T he effec t o f  diffe ren t thiol d rugs and  2 -m e th y l-th iazo ]id in e -2 ,4 -d ica rb o x y !ic  acid on the  ox idative 
stress, induced  by hydrogen  perox ide, w as exam ined  in hum an  ery th rocy tes. T he results indicated  tha t captopril 
(C A ), m eth im azo le , N -ace ty lcy s te in e  (N A C ), pen ic illam ine  and  p recu rso r o f  L -c y ste in e  2 -m e th y l-th iazo lid i-  
n e -2 ,4 -d ica rb o x y lic  ac id  (C P) m ight p ro tect the ery th rocy te  m em brane aga inst lip id  perox idation  in the 
experim en tal conditions. C ap topril, m e th im azo le and pen ic illam ine  had  the strongest an tiox ida tive properties at 
the concen tra tion  level o f  0.5 m M . T he p ro tec tive  effec ts  g radually  decreased  at h ighe r and low er 
concen trations o f  these drugs. C on tra ry , the an tiox ida tive properties o f  N -ace ty lcy s te in e  increased  w ith  its 
levels g row ing  in the reaction  m ixture, and  only  N -ace ty lp en ic illam in e  d id  not p ro tect ery th rocy tes  against 
ox ida tive  dam ages. T he effec t o f  2 -m e th y l- th iazo lid in e -2 ,4 —dicarboxy lic  ac id  show ed  in these in vitro  
experim en tal cond itions that it could  ac t as an an tiox idan t at the concen tration  as h igh  as 5 m M  and h igher.
K e y w o rd s: cap topril /  m e th im azo le /  N -ace ty lcy s te in e  / pen icillam ine /  N -ace ty lp en ic illam in e  /  2 -m e - 
th y l- th ia zo lid in e -2 ,4 -d ic a rb o x y lic  ac id  /  ox ida tive  hem olysis
Studies in vitro  dem onstrate that thiols can 
have both a n ti-  and prooxidative effect depending 
on their concentration, the presence o f transitory 
metal ions, the pK  value o f  the sulphydryl group, 
and even on the polarity o f the environm ent (1). 
The protective effect o f  thiols is associated with 
their ability to react with reactive oxygen species, 
while their prooxidative effect is related to their 
spontaneous oxidation to sulphides, as well as to 
the form ation o f  thiyl radicals (2,3). N um erous 
drugs characterized by a different pharm acological 
profile contain sulphydryl groups the presence o f 
which m ay trigger both a p ro -  and antioxidative 
effect. In o ther words, their side effect may be both, 
beneficial and disadvantageous for the cells. The 
inves tiga tions in th is paper inc luded  d rugs co n ­
ta in ing  the -S H  group  and  hav ing  d iversif ied  
pharm aco log ica l p ropertie s , such as cap topril, 
m eth im azo le , N -ace ty lcy s te in e  and  p en ic illam i­
ne, as w ell as com pounds w hich have no m edical 
app lica tion , 2 -m e th y l- th ia z o lid in e -2 ,4 -d ic a rb o -  
xylic ac id  and N -ace ty lp en ic illam in e . C ap topril 
reduces b lood  p ressu re  as a specific  com petitive  
in h ib ito r o f  ang io ten sin e  convertase . It is know n 
to m an ifest an tiox ida tive  p ro p ertie s  (4 ,5 ,6 ). M e­
th im azo le , an o th e r drug under ou r investiga tion , 
is em ployed  in hyperthy ro id ism . T o date , it is 
little  know n about its a n t i -  o r p ro o x id a tiv e  effec t 
bu t it w as found  to  ac t as an an tio x id an t reducing  
the nephro tox ic  ac tiv ity  o f  gen tam ycin  (7). N -a -  
ce ty lcy ste in e  (N A C ) is a  com m only  used  m uco ­
ly tic  and hep a to p ro tec tiv e  agen t w hich show s 
an tiox ida tive  p ropertie s  (8). 2 -M e th y l- th ia z o li-  
d in e -2 ,4 -d ic a rb o x y lic  acid  (C P) is a p roduc t o f 
n o n -en zy m a tic  co ncen tra tion  o f  py ruvate  and 
cyste ine  and show s h ep a top ro tec tive  p roperties 
(8 ,9 ,10).
The effect o f the above m entioned thiols on 
oxidative processes w as studied in hum an eryth­
rocytes w here oxidation w as induced by hydrogen 
peroxide in the presence o f  natrium  azide, a catala- 
se inhibitor. The effect o f the above thiols was 
studied within a given concentration ranges 0.1 
mM  -  2.0 m M  for CA, m ethim azole, NAC, penicil­
lam ine, N -acetylpenicillam ine, and 0.1 m M  -  25 
mM  for CP. The levels o f  m alonyldialdehyde 
(M D A ), reactive oxygen species (RO S) and hem o­
globin released w ere evaluated as the m easure o f 
red cell peroxidative hem olysis.
EXPERIMENTAL 
Chemicals
2-T hiobarb itu ric  acid, N -acety lcysteine, 2 ’, 
7 ’-d ich lo ro  fluorescein w ere obtained from  Sigm a 
C hem ical Co (G erm any) w hereas m ethim azole and 
N -ace ty l-D L -p en ic illam in e  from  Sigm a Chem ical 
C o (St. L ouis U SA). Trichloroacetic acid was 
purchased from  U bichem  pic Sigm a Chem ical Co, 
captopril from  Fluka C hem ie A G C H -9470  Buchs. 
D - L -  penicillam ine and 2 ’,7 ’-d ichlorofluorescein  
diacetate w ere purchased from Serva Feinbioche-
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m ica (H eidelberg) and M olecular Probes Eugene 
O R (USA), respectively. 2 -M ethy l-th iazo lid ine-2 , 
4 -d icarboxylic  acid w as synthesized in the Labora­
tory of Chem ical Synthesis o f the Jagiellonian 
University.
Isolation of erythrocytes
H um an blood was obtained from  healthy vo­
lunteers and was sam pled into natrium  citrate 
containing tubes. The cells w ere separated by 
centrifugation at 2500 g for 10 min. The ery th­
rocytes were w ashed three tim es w ith the sam e 
volum e o f physiological saline.
Reaction mixtures
Each reaction m ixture in a final volum e of 
2 ml contained 0.2 ml o f packed red cells. The final 
concentration o f  natrium  azide w as 2 mM , of 
hydrogen peroxide 10 mM , and o f the thiol com ­
pounds 0.1, 0.5, 1.0, and 2.0 mM . S im ultaneously, 
control sam ples w ithout thiols w ere prepared. The 
sam ples w ere adjusted to  a final volum e with 
phosphate-buffered  saline (0.9%  NaCl, 5 mM  so­
dium /potassium  phosphate, pH 7.4) and then were 
incubated for 30 min at 37°C.
Lipid peroxidation assay
Lipid peroxidation was m easured in reaction 
with thiobarbituric acid (TBA) in acid m edium  (11) 
and was expressed as m icrom oles o f m alonyldial- 
dehyde per g o f hem oglobin in reaction mixture. 
A fter incubation, 0.25 ml o f reaction m ixture was 
deproteinized w ith 2 ml o f  28%  trichloroacetic acid 
and then centrifuged at 2500 g for 10 min. Next 
2 ml o f the supernatant was m ixed w ith 0.5 ml of 
0.9%  TBA  and heated at 100°C for 10 min. The 
absorbance o f  the coloured product was m easured 
at 535 nm.
Reactive oxygen species (ROS) assay
Reactive oxygen species w ere assayed fluoro- 
m etrically according to the m ethod o f  B ondy (12).
0.01 ml o f  erythrocytes suspension was incubated 
w ith 0.01 ml o f 2 ’,7 ’-d ich lorofluorescein  diacetate 
in a final volum e o f 1 ml phosphate buffer pH 7.4 at 
37°C for 30 min. Then sam ples w ere centrifuged at
T able 1. E ffect o f  various cap topril concen tra tions on lip id  perox idation  (M D A ), reactive oxygen species (R O S) and  tree  hem oglobin  
levels.
C ontrol C aptopril
0,1 mM 0,5 mM 1 mM 2 mM
MDA
gm ol/g Hb
0.304 ±  0,022 0 ,2 11* *  ±  0,017 0,179** ± 0,006 0,183** ± 0,005 0,262* + 0,025
ROS
pm ol/g Hb
4,236 ± 0,373 3,125* + 0,141 2,789* + 0,119 3,119* + 0,155 3,535* ± 0,266
Hb
g/cm3
0,120 ± 0,004 0,083* ± 0 ,0 1 2 0,071* ± 0,004 0,076* ± 0,003 0,101* ±  0,006
*p<0,05; **p<0,001
T ab le  2. E ffec t o f  various m eth im azo le concen tra tions on lip id  perox idation  (M D A ), reactive oxygen species (R O S) and  free hem oglobin  
levels.
C ontrol M ethim azole
0,1 mM 0,5 mM 1 mM 2 mM
MDA
limol/g Hb
0,295 + 0,020 0,229* ± 0,012 0,201* ±  0,018 0,229* ±  0,020 0,262 ±  0,022
R O S
pmol/g Hb
4,216 ± 0,199 3,515 * ± 0,129 3,150** ±  0,077 3,353** ± 0,065 3,403 ±  0,411
H b
g/cm3
0,120 ± 0,004 0,106* ± 0,006 0,084* ± 0,004 0,088* ± 0,005 0,107 ±  0,006
*p<0,05; **p<0,001
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T able 3 .E ffect o f  various pen ic illam ine  concen tra tions on lipid perox idation  (M D A ), reactive oxygen  species (R O S) and free hem oglobin  
levels.
C ontrol Penicillam ine
0,1 mM 0,5 mM I mM 2 mM
MDA
pmol/g Hb
0,292 ± 0,008 0,234* ± 0 ,0 1 2 0,221* ±0,011 0,233* ± 0 ,0 1 0 0,253* ± 0 ,0 1 0
ROS
pmol/g Hb
4,048 ± 0,262 3,465** ± 0,221 3,262** ± 0,145 3,432* ± 0 ,1 1 5 3,635* ±  0,122
H b
g/cm3
0,120 ± 0,004 0,107* ± 0,004 0,103* ± 0,003 0,108* ± 0,004 0,115* ± 0,006
*p<(X05; **p<0,001
T ab le  4. E ffect o f  various D ,L -ace ty lp en ie illam in e  concen tra tions on lipid perox idation  (M D A ), reac tive  oxygen species (R O S) and free 
hem oglob in  levels.
C ontrol D ,L-acetylpenicillam ine
0,1 mM 0,5 mM 1 mM 2 mM
MDA
pmol/g Hb
0,290 ± 0 ,0 1 6 0,268 ± 0 ,0 1 2 0,272 ± 0 ,0 1 4 0,272 ± 0 ,0 1 9 0,276 ± 0 ,0 1 0
ROS
pm ol/g Hb
4,145 ± 0,150 4,156 ± 0,112 4,162 ± 0,095 4,151 ± 0,162 3,940 ± 0 ,1 5 6
H b
g/cm ’
0,120 ± 0,004 0,121 ± 0,005 0,121 ± 0,020 0,120 ± 0,004 0,120 ± 0,004
T able 5 . E ffec t o f  various N -ace ty lcy ste in e  concen trations on lipid perox idation  (M D A ), reactive oxygen  species (R O S) and  free 
hem oglob in  levels.
C ontrol N -acetylcysteine
0,1 mM 0,5 mM 1 mM 2 mM
MDA
pm ol/g Hb
0,280 ±0 ,011 0,243* ± 0 ,0 1 0 0,225* ± 0,015 0,214* ± 0,017 0,203* ± 0 ,0 1 2
ROS
pm ol/g Hb
4,145 ±  0,220 3,594* ± 0 ,1 5 0 3,430* ± 0,165 3,289* ± 0 ,1 6 7 3,084* ± 0,226
Hb
g/cm3
0,120 ±  0,006 0,107* ± 0,005 0,101* ± 0,009 0,095* ± 0 ,0 1 0 0,086* ± 0,008
*p<0.05
12000 g for 8 min at 4°C. The excitation w ave­
length was 488 nm and the em ission wavelength 
525 nm. The level o f  ROS w as expressed as 
m icrom oles o f 2 ’,7 ’-d ich lorofluoresceine per g of 
hem oglobin in reaction m ixture.
Hemoglobin released assay
The amount o f hemoglobin released was deter­
mined according to the method o f Drabkin (13). The
reaction mixture after incubation was centrifuged at 
2500 g for 10 min, then the amount o f hemoglobin in 
the supernatant was determined. To 5 ml o f Drabkin 
reagent 0.2 ml o f supernatant was added and after 20 
min extinction was measured at 540 nm.
Statistical methods
S tu d en t’s t - te s t  w as used fo r sta tistica l ana­
lysis and a p  value o f  <0.05 w as co nsidered





F igure 1. E ffec t o f  various 2 -m e ty lth iazo lid in e -2 ,4 —dicarbox ilic  
ac id  concen trations on lipid perox idation  (M D A ), reactive oxygen 
species (R O S) and free hem oglob in  levels.
sign ifican t. V alues are  exp ressed  as m eans 
±  SEM .
RESULTS
The control sam ples containing none o f  the 
studied com pounds w ere characterized by a  high 
level o f  M D A , ROS and hem oglobin released.
All the investigated concentration values of 
captopril w ere found to significantly decrease ox i­
dative hem olysis (Table 1). The greatest drop in the 
level o f M D A, ROS and released hem oglobin was 
noted at 0.5 mM , w hen the level o f M D A  decreased 
to 58% , ROS dim inished to  65%  and hem oglobin 
to 59%  o f the control sam ples. A t higher concent­
ration values, the antioxidative effect o f  captopril 
w as weaker.
S im ilarly as in the case o f captopril, all the 
studied m ethim azole concentration values resulted 
in a significant decrease o f  the M D A , ROS and 
hem oglobin levels (Table 2). All these param eters 
reached their low est values at the m ethim azole 
concentration o f  0.5 mM . A t this level the value o f 
M D A  dropped to 68% , ROS to 74%  and free 
hem oglobin to 70% o f the control values. These 
levels gradually increased at higher and low er 
m ethim azole concentrations.
Penicillam ine w as proved to exert a beneficial 
effect on a drop o f all the investigated param eters 
(Table 3). A lso in this case the low est level o f 
M D A, ROS and free hem oglobin w as noted at 0.5
mM . The level o f M D A  reached 75%  o f the 
controls w hile for ROS, the value w as 80%, for free 
hem oglobin 90% . These values also increased at 
higher and low er penicillam ine levels.
Studies on N -acetylpenicillam ine dem onstra­
ted that the com pound exerted no protective effect 
against oxidative dam age o f  the cells. N one o f the 
investigated D ,L -acetylpenicillam ine concentra­
tion levels resulted in the decrease o f  M D A, ROS 
and free hem oglobin values, or these values were 
d im inished only negligibly (Table 4).
Investigations carried out on NAC (Table 5) 
confirmed its antioxidative properties. It is showed 
that the level o f M DA, ROS, hemolysis and free 
hemoglobin decreased with the increase in NAC 
concentration. For the most beneficial and at the same 
tim e the highest NAC concentration level (2.0 mM), 
the value o f M D A  dropped to 72%, ROS to 74% and 
free hemoglobin to 71% of the control levels.
Figure 1 illustrates the effect o f various CP 
concentration values on the level o f  M D A , ROS 
and free hem oglobin. The association w as studied 
for the concentration range o f 0 .01 -25 .0  mM . The 
results indicated that in the experim ental conditions 
in vitro, the protective effect o f CP could be 
observed only at 5 .0 -25 .0  mM . A t the highest 
concentration (25.0 mM ), the level o f M D A  dec­
reased to 68% , ROS to 61% , and free hem oglobin 
to  59%  o f the control values.
DISCUSSION
The present investigations dem onstrated that 
w hen hum an erythrocytes w ere exposed to hydro­
gen peroxide in the presence o f natrium  azide, the 
levels o f  M D A, ROS and hem olysis rose rapidly in 
com parison to sam ples containing hydrogen pero­
xide itself or natrium  azide only. This supports our 
hypothesis that hem olysis results from  peroxidative 
dam ages o f  biological m em branes and o ther ce l­
lular structures inflicted by hydrogen peroxide. The 
studies show ed that erythrocytes w ere characteri­
zed by high resistance to  hydrogen peroxide and, 
thus, in our experim ent it was necessary to em ploy 
high concentrations o f  the com pound (10 m M ) in 
the presence o f  natrium  azide, a catalase inhibitor. 
O nly in such conditions the erythrocyte antioxidati­
ve system s break down, w hich ultim ately leads to 
hemolysis.
The investigations included the group o f thiols 
which, as it is well know n, due to their sulphydryl 
group could m anifest changeable and contrary ef­
fects in p ro -  and antioxidative processes (4, 5, 
14,15). The results dem onstrate that in the ex­
perim ental conditions at 0.5 m M  concentration,
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captopril, m ethim azole and penicillam ine exert the 
strongest protective effect on erythrocytes. In this 
group, the m ost pronounced antioxidative activity 
is characteristic o f captopril.
N -acety lcysteine behaves differently, because 
its antioxidative properties increase with increasing 
N AC concentration in reaction mixture. It seem s to 
confirm  its generally accepted low toxicity. M ost 
likely, in order to  visualize a drop in its protective 
effect, investigations should be carried out on the 
com pound with higher concentration values. C ont­
rary to penicillam ine (Table 3), N -acety lpen icil- 
lam ine (Table 4) has no effect on oxidative proces­
ses in erythrocytes and it show s that acetylation by 
nitrogen results in a total loss o f  protective proper­
ties o f this com pound.
In this work, 2 -m ethy l-th iazo lid ine-2 ,4 -d icar- 
boxylic acid  (CP), a  product o f non -enzym atic  
condensation  o f cysteine and pyruvate re leased  in 
a reverse reaction  sim ultaneously  tw o an tiox i­
dants: cysteine necessary  for the G SH  b iosyn t­
hesis and pyruvate. The la tter ke toac id  proved  to 
exert the an tiox idative properties (8, 16). In the 
prev ious studies in vivo  and in vitro, C P  w as 
proved  to  have an effective and lo n g -la stin g  (up 
to 12 hours) hepatopro tective effect in ethyl al­
cohol (17) and paracetam ol in tox ication  (18). T his 
is w hy the 3 0 -m in u te  incubation  o f  2 -m e t-  
h y l- th iazo lid in e -2 ,4 -d ica rb o x y lic  acid  w ith ery t­
hrocyte suspension w as m ost likely too short to 
allow  any p ro tective effec t o f  low er CP concen t­
rations to be noted.
The prooxidative activity o f  thiols dem onst­
rated w ith use o f free cysteine as an exam ple, 
show ing that both, its deficit and its excess can 
induce hem olysis (8). A  sim ilar concen tra tion -de­
pendent effect on hem olysis is exerted by penicil­
lam ine (19). In the present investigations, the con­
centration o f penicillam ine at w hich its m axim um  
protective effect against hydrogen peroxide is no­
ted is identical w ith the value observed by Lovstad 
(19) at w hich he also noted the low est level o f 
hem olysis. A  decrease in protective properties ob­
served at higher concentration levels o f the studied 
thiols is m ost likely related to the oxidation o f  their 
sulphydryl groups to corresponding disulphides and 
the possible form ation o f disulphide and thiyl 
radicals. N o such concentration o f NAC w as iden­
tified in the present studies at w hich its protective 
effect on erythrocytes w ould be decreased, as it 
could be observed in the case o f the other thiol 
drugs. In the in vivo  experim ent conduced by 
Sprang et al. (20), low er doses o f N AC w ere found 
to decrease the blood hydrogen peroxide level and 
to  dim inish the m ortality rate in rats w hile high
doses o f  NAC resulted in the decrease o f  pul­
m onary G SH  and increase o f  m ortality .
The antioxidative effect o f captopril was first 
dem onstrated by A ndreoli (4). The observation that 
in vitro, in an acellular system  captopril is a stron­
ger antioxidant than cysteine appears very interes­
ting. Fernandes (21) found that captopril was a m o­
re effective antioxidant than enalapril or lisinopril 
-  other angiotensine convertase inhibitors w hich do 
not contain the thiol group. It suggests that the 
protective properties o f CA are associated w ith the 
free -S H  group. The investigations o f G olik (5) and 
A ltuntas (6) dem onstrated that blood concentration 
levels o f  M D A  in patients subjected to long-term  
captopril therapy significantly decreased w hich 
confirm s the antioxidative properties o f the drug. 
O ther studies by L appena proved that in the presen­
ce o f  iron or copper ions captopril exhibited pro­
oxidative effects and, thus, it could not be treated 
as a sim ple antioxidative agent. A specific binding 
o f  copper by captopril induces its prooxidative 
activity. S im ultaneously, penicillam ine has an an­
tioxidative effect in the presence o f copper, and 
a prooxidative effect in the presence o f iron (22). 
T he prooxidative ability o f captopril and penicil­
lam ine w hich is regulated by the presence o f 
transitory m etals m ust, then, be taken into con­
sideration in experim ental studies and clinical tra­
ils. These reports are confirm ed by B artosz who 
states that deoxyribose degradation induced by iron 
o r copper ions is intensified under the influence o f 
captopril (15).
Sum m ing up, the investigations, o f m ethim a­
zole, captopril, N AC and penicillam ine irrespec­
tively o f their m ain pharm acological usage can be 
said to  exhibit in vitro  concentration-dependent 
antioxidative activities w hich in this case can be 
regarded as a beneficial side effect. O ne should 
bear in m ind that thiol drugs, as well as all the 
com pounds containing the -S H  groups, may also 
dem onstrate adverse prooxidative properties w ithin 
at certain concentration ranges and in the presence 
o f transitory metals.
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